Abiraterone Acetate Tablet
Product Images NDC 50268-032

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 50268-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (032 12)

Abiraterone Acetate Tablets, USP 250 mg oral tablets by AvPAK. The label indicates a package containing 20 tablets (2 x 10). It includes warnings for use by women who are or may be pregnant, storage instructions at controlled room temperature (20°C to 25°C), and advises swallowing tablets whole without crushing or chewing. Manufactured by AvKARE in Pulaski, TN.*

FDA Label Image

Figure1 (Figure1)

A survival curve graph comparing percentage survival over time in months between Abiraterone Acetate and placebo groups, with survival percentage on the y-axis and time to death in months on the x-axis. The graph includes the number of subjects at risk at several time points for both treatments.*

FDA Label Image

Figure2 (Figure2)

A Kaplan-Meier survival curve chart depicting the percentage of subjects without death over months from randomization, comparing Abiraterone Acetate to placebo. The X-axis represents months from randomization, and the Y-axis shows the percentage of subjects without death, illustrating survival over time for the two groups.*

FDA Label Image

Figure3 (Figure3)

A survival curve chart depicting the percentage of subjects without radiographic progression or death over months from randomization. Two lines represent placebo (dashed) and Abiraterone Acetate (solid), showing higher survival without progression for Abiraterone Acetate over time. Participant numbers at risk are listed below the time axis for both groups.*

FDA Label Image

Figure4 (Figure4)

A Kaplan-Meier survival curve graph depicting the percentage of subjects without death over months from randomization comparing Abiraterone Acetate and Placebo groups. The x-axis shows months from 0 to 72, and the y-axis shows % survival from 0% to 100%. Data points and survival tables for subjects at risk for both groups are displayed below the curves.*

FDA Label Image

Structure (Structure)

Chemical structure of Abiraterone Acetate, showing its steroid backbone with attached functional groups including a pyridine ring and acetate ester.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.